Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis

Oral Diseases

Volumn 21, Issue 6, 2015, Pages 705-712

  Lee, J K ^a   Kim, S J ^b   Ko, S H ^a   Ouwehand, A C ^c   Ma, D S ^a  

^a Gangneung Wonju National University   (South Korea)

^b KSJ Probioticslab   (South Korea)

^c DUPONT COMPANY   (United States)

Author keywords

Lactobacillus brevis; Gingival crevicular fluid; Gingivitis; Probiotics

Indexed keywords

NEUTROPHIL COLLAGENASE; NITRIC OXIDE; PLACEBO; PROBIOTIC AGENT; PROSTAGLANDIN E2;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; LACTOBACILLUS BREVIS; LOZENGE; MALE; MOUTH HYGIENE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; DOUBLE BLIND PROCEDURE; METABOLISM; PERIODONTAL INDEX; PLAQUE INDEX;

DENTAL PLAQUE INDEX; DINOPROSTONE; DOUBLE-BLIND METHOD; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; LACTOBACILLUS BREVIS; MALE; NITRIC OXIDE; PERIODONTAL INDEX; PROBIOTICS;

EID: 84938745343     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12332     Document Type: Article

References (39)

1. Buduneli N, Kinane DF (2011). Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 38(Suppl. 11): 85-105.
2. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002). Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324: 1361.
3. Gill H, Prasad J (2008). Probiotics, immunomodulation, and health benefits. In: Bösze Z, ed. Bioactive components of milk. Springer: New York, pp. 423-454.
4. Gionchetti P, Rizzello F, Helwig U et al (2003). Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
5. Greenstein G (1984). The role of bleeding upon probing in the diagnosis of periodontal disease. A literature review. J Periodontol 55: 684-688.
6. Ierardo G, Bossù M, Tarantino D et al (2010). The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric study. Ann Stomatol (Roma) 1: 8-13.
7. Iniesta M, Herrera D, Montero E et al (2012). Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J Clin Periodontol 39: 736-744.
8. Karuppaiah RM, Shankar S, Raj SK et al (2013). Evaluation of the efficacy of probiotics in plaque reduction and gingival health maintenance among school children: a randomized control trial. J Int Oral Health 5: 33-37.
9. Kõll-Klais P, Mändar R, Leibur E et al (2005). Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 20: 354-361.
10. Krasse P, Carlsson B, Dahl C et al (2006). Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 30: 55-60.
11. Lie MA, Danser MM, van der Weijden GA et al (1995). Oral microbiota in subjects with a weak or strong response in experimental gingivitis. J Clin Periodontol 22: 642-647.
12. Linsalata M, Russo F, Berloco P et al (2004). The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9: 165-172.
13. Löe H, Silness J (1963). Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontol Scand 21: 533-551.
14. Löe H, Theilade E, Jensen SB (1965). Experimental gingivitis in man. J Periodontol 36: 177-187.
15. Löe H, Theilade E, Jensen SB, SchiØtt CR (1967). Experimental gingivitis in man. J Periodontal Res 2: 282-289.
16. Maekawa T, Hajishengallis G (2014). Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodontal Res 49: 785-791.
17. Marzio LD, Russo FP, D'Alò S et al (2001). Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer 40: 185-196.
18. Mimura T, Rizzello F, Helwig U et al (2004). Once daily high dose probiotic therapy (VSL# 3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
19. Müller HP, Barrieshi-Nusair KM, Könönen E, Yang M (2006). Effect of triclosan/copolymer-containing toothpaste on the association between plaque and gingival bleeding: a randomized controlled clinical trial. J Clin Periodontol 33: 811-818.
20. Nascimento MM, Gordan VV, Garvan CW, Browngardt CM, Burne RA (2009). Correlations of oral bacterial arginine and urea catabolism with caries experience. Oral Microbiol Immunol 24: 89-95.
21. Niscola P, Tendas A, Scaramucci L et al (2012). Aphthous oral ulceration and its successful management by Lactobacillus brevis CD2 extract in an adult haemophilic patient. Haemophilia 18: e78-e79.
22. Offenbacher S, Barros S, Mendoza L et al (2010). Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans. J Clin Periodontol 37: 324-333.
23. Paquette DW, Rosenberg A, Lohinai Z et al (2006). Inhibition of experimental gingivitis in beagle dogs with topical mercaptoalkylguanidines. J Periodontol 77: 385-391.
24. Riccia DN, Bizzini F, Perilli MG et al (2007). Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis 13: 376-385.
25. Rijkers GT, Bengmark S, Enck P et al (2010). Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 140: 671S-676S.
26. Salvi GE, Lang NP (2005). Host response modulation in the management of periodontal diseases. J Clin Periodontol 32: 108-129.
27. Scapoli C, Tatakis DN, Mamolini E, Trombelli L (2005). Modulation of clinical expression of plaque-induced gingivitis: interleukin-1 gene cluster polymorphisms. J Periodontol 76: 49-56.
28. Scapoli C, Mamolini E, Trombelli L (2007). Role of IL-6, TNF-A and LT-A variants in the modulation of the clinical expression of plaque-induced gingivitis. J Clin Periodontol 34: 1031-1038.
29. Shimauchi H, Mayanagi G, Nakaya S et al (2008). Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 35: 897-905.
30. Silness J, Loe H (1964). Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22: 121-135.
31. Staab B, Eick S, Knofler G, Jentsch H (2009). The influence of a probiotic milk drink on the development of gingivitis: a pilot study. J Clin Periodontol 36: 850-856.
32. Tasli L, Mat C, De Simone C, Yazici H (2006). Lactobacilli lozenges in the management of oral ulcers of Behcet's syndrome. Clin Exp Rheumatol 24: S83-S86.
33. Teughels W, Newman MG, Coucke W et al (2007). Guiding periodontal pocket recolonization: a proof of concept. J Dent Res 86: 1078-1082.
34. Theilade E, Wright WH, Jensen SB, Löe H (1966). Experimental gingivitis in man. J Periodontal Res 1: 1-13.
35. Trombelli L, Tatakis DN, Scapoli C et al (2004). Modulation of clinical expression of plaque-induced gingivitis. J Clin Periodontol 31: 239-252.
36. Twetman S, Derawi B, Keller M et al (2009). Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 67: 19-24.
37. Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002). Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109: 678-684.
38. Vanderhoof JA, Whitney DB, Antonson DL et al (1999). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135: 564-568.
39. Vuotto C, Barbanti F, Mastrantonio P, Donelli G (2014). Lactobacillus brevis CD2 inhibits Prevotella melaninogenica biofilm. Oral Dis 20: 668-674.